BR9504456A - Compostos e processo para sua preparaçao seu uso e medicamento e processo para sua preparaçao - Google Patents

Compostos e processo para sua preparaçao seu uso e medicamento e processo para sua preparaçao

Info

Publication number
BR9504456A
BR9504456A BR9504456A BR9504456A BR9504456A BR 9504456 A BR9504456 A BR 9504456A BR 9504456 A BR9504456 A BR 9504456A BR 9504456 A BR9504456 A BR 9504456A BR 9504456 A BR9504456 A BR 9504456A
Authority
BR
Brazil
Prior art keywords
preparation
medicine
compounds
alkoxy
formula
Prior art date
Application number
BR9504456A
Other languages
English (en)
Inventor
Manfred Dr Roesner
Uta-Maria Billhardt-Troughton
Reinhard Dr Kirsch
Joerg-Peter Dr Kleim
Christoph Dr Meichsner
Guenther Dr Ries
Irvin Dr Winkler
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of BR9504456A publication Critical patent/BR9504456A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40—Benzopyrazines
    • C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Dental Preparations (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BR9504456A 1994-10-19 1995-10-19 Compostos e processo para sua preparaçao seu uso e medicamento e processo para sua preparaçao BR9504456A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4437406A DE4437406A1 (de) 1994-10-19 1994-10-19 Chinoxaline, Verfahren zu ihrer Herstellung und ihre Verwendung

Publications (1)

Publication Number Publication Date
BR9504456A true BR9504456A (pt) 1997-05-20

Family

ID=6531202

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9504456A BR9504456A (pt) 1994-10-19 1995-10-19 Compostos e processo para sua preparaçao seu uso e medicamento e processo para sua preparaçao

Country Status (28)

Country Link
US (1) US5723461A (pt)
EP (1) EP0708093B1 (pt)
JP (1) JPH08225544A (pt)
KR (1) KR960014108A (pt)
CN (1) CN1094930C (pt)
AT (1) ATE198747T1 (pt)
AU (1) AU708293B2 (pt)
BR (1) BR9504456A (pt)
CA (1) CA2160859A1 (pt)
CZ (1) CZ271295A3 (pt)
DE (2) DE4437406A1 (pt)
DK (1) DK0708093T3 (pt)
ES (1) ES2154311T3 (pt)
FI (1) FI954946A (pt)
GR (1) GR3035673T3 (pt)
HK (1) HK1011988A1 (pt)
HR (1) HRP950524B1 (pt)
HU (1) HUT73485A (pt)
IL (1) IL115641A0 (pt)
MY (1) MY132057A (pt)
NO (1) NO306615B1 (pt)
NZ (1) NZ280258A (pt)
PL (1) PL184860B1 (pt)
PT (1) PT708093E (pt)
SI (1) SI9500329A (pt)
SK (1) SK128495A3 (pt)
TW (1) TW328954B (pt)
ZA (1) ZA958783B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6369057B1 (en) * 1991-04-15 2002-04-09 Aventis Pharma Deutschland Gmbh Quinoxalines, processes for their preparation and their use
US6015800A (en) * 1997-09-03 2000-01-18 Warner-Lambert Company Substituted quinoxaline-2-ones as glutamate receptor antagonists
WO1999025327A2 (en) * 1997-11-14 1999-05-27 Warner-Lambert Company Small molecule intervention in hiv-1 replication
GB9901795D0 (en) * 1999-01-28 1999-03-17 Glaxo Group Ltd Chemical compounds
GB9911887D0 (en) * 1999-05-21 1999-07-21 Glaxo Group Ltd Methods and medicaments for post exposure prophylaxis of an hiv infection
US20030114385A1 (en) * 2001-04-27 2003-06-19 Cathers Brian E. Viral enzyme activated prototoxophores and use of same to treat viral infections
WO2005018531A2 (fr) * 2003-08-26 2005-03-03 'chemical Diversity Research Institute', Ltd. Compositions pharmaceutiques, composes azo-heterocycliques et procedes de fabrication et d'utilisation correspondants
US7351709B2 (en) * 2004-06-09 2008-04-01 Wyeth Estrogen receptor ligands
WO2013163190A1 (en) 2012-04-24 2013-10-31 Vertex Pharmaceutical Incorporated Dna-pk inhibitors
LT2970218T (lt) 2013-03-12 2019-03-12 Vertex Pharmaceuticals Incorporated Dna-pk inhibitoriai
SG11201602962PA (en) 2013-10-17 2016-05-30 Vertex Pharma Co-crystals of (s)-n-methyl-8-(1-((2'-methyl-[4,5'-bipyrimidin]-6-yl)amino)propan-2-yl)quinoline-4-carboxamide and deuterated derivatives thereof as dna-pk inhibitors
KR20190062485A (ko) 2016-09-27 2019-06-05 버텍스 파마슈티칼스 인코포레이티드 Dna-손상제 및 dna-pk 저해제의 조합을 사용한 암 치료 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59209965D1 (de) * 1991-04-15 2002-10-17 Aventis Pharma Gmbh Chinoxaline, Verfahren zu ihrer Herstellung und ihre Verwendung
DE4342024A1 (de) * 1993-12-09 1995-06-14 Hoechst Ag Kombinationspräparate, enthaltend ein Chinoxalin und ein Nukleosid

Also Published As

Publication number Publication date
SK128495A3 (en) 1996-06-05
HRP950524B1 (en) 2002-06-30
JPH08225544A (ja) 1996-09-03
DE59508969D1 (de) 2001-02-22
KR960014108A (ko) 1996-05-22
FI954946A0 (fi) 1995-10-17
HU9503005D0 (en) 1995-12-28
NO306615B1 (no) 1999-11-29
US5723461A (en) 1998-03-03
CN1094930C (zh) 2002-11-27
ATE198747T1 (de) 2001-02-15
DK0708093T3 (da) 2001-04-30
MY132057A (en) 2007-09-28
AU708293B2 (en) 1999-07-29
EP0708093B1 (de) 2001-01-17
AU3431695A (en) 1996-05-02
PL184860B1 (pl) 2003-01-31
NO954139L (no) 1996-04-22
EP0708093A1 (de) 1996-04-24
NZ280258A (en) 1997-09-22
CZ271295A3 (en) 1996-08-14
GR3035673T3 (en) 2001-06-29
ES2154311T3 (es) 2001-04-01
HK1011988A1 (en) 1999-07-23
TW328954B (en) 1998-04-01
ZA958783B (en) 1996-05-09
FI954946A (fi) 1996-04-20
IL115641A0 (en) 1996-01-19
CA2160859A1 (en) 1996-04-20
PL311016A1 (en) 1996-04-29
HRP950524A2 (en) 1997-10-31
SI9500329A (en) 1996-04-30
PT708093E (pt) 2001-06-29
NO954139D0 (no) 1995-10-18
DE4437406A1 (de) 1996-04-25
CN1135483A (zh) 1996-11-13
HUT73485A (en) 1996-08-28

Similar Documents

Publication Publication Date Title
BR9504456A (pt) Compostos e processo para sua preparaçao seu uso e medicamento e processo para sua preparaçao
ZA918331B (en) Antimicrobial agents as well as substituted 2-cyclohexan-1-yl-amine derivatives and their preparation
DE3783238D1 (de) Substituierte 2,4-diamino-5-benzylpyrimidine, deren herstellung und deren verwendung als arzneimittel mit antimikrobieller wirksamkeit.
DE3882544D1 (de) Substituierte 3,4-dihydro-2h-benzopyrane, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen.
IL117150A (en) Substituted benzenesulfonylureas and - thioureas processes for their preparation their use in the preparation of medicaments and pharmaceutical compositions containing them
PT99468A (pt) Processo para a preparacao de compostos cefem 7-actil-3-(carbamoiloxi substituido) com propriedades antibacterianas
FI923458A0 (fi) 4,5-cykloalkano-3-benzazepin-7-ol- derivat och deras anvaendning.
TW216795B (en) 3-substituted methyl-2,3-dihydroimidazo[1,2-c]quinazoline derivatives, the preparation and use thereof
DE3869144D1 (de) 5-(3-alkyl-5-tert.butyl-4-hydroxyphenyl)-2-amino-6h-1,3,4-thiadiazine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung.
ATE15045T1 (de) Cephalosporinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
KR910005867A (ko) 배뇨 장해 치료제
EP0487996B1 (de) 3-substituierte Cephalosporine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
HUT76480A (en) Alkyl-5-methyl-sulphonyl-benzoyl-guanidine derivatives, process for the preparation thereof and pharmaceutical compositions containing them
ES8604591A1 (es) Procedimiento para preparar nuevas 11-piperazinil-5h-imidazo(2,1-c)(1,4)-benzodiazepinas
DE69403896D1 (de) 4-amino-2-(hetero)aryl-butanamide verwenbar als 5-ht1a-antagonisten
FI933652A (fi) Foerfarande foer framstaellning av 1-osubstituerade 3-aminopyrroler

Legal Events

Date Code Title Description
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
PC Transfer

Free format text: AVENTIS PHARMA DEUTSCHLAND GMBH (DE)

HJEG Technical examination (opinion): technical examination (opinion) related to article 229 of industrial property law
FG9A Patent or certificate of addition granted
B24C Patent annual fee: request for for restoration

Free format text: REFERENTE 9A., 10A., 11A., 12A., 13A., E 14A. ANUIDADES.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 2049 DE 13/04/2010 E COMPROVAR RECOLHIMENTO DA 15A , 16A , 17A E 18A ANUIDADES.